SecBot SecBot
6-K ·Filed Jul 22, 2026

ICLR

ICON PLC
NEUTRAL
Impact 4/10
Horizondays Processed3mo ago SEC0001628280-26-049100
Notable filing: 6-K
Actionable Insight • Neutral

This filing itself is non-eventful, but the upcoming Q2 earnings release on July 29 is a critical catalyst given the prior restatement and control weaknesses. Traders should position for elevated volatility around the earnings call, with particular focus on revenue quality, backlog trends, and any updates on remediation of material weaknesses.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$167.28
T+0 close · Jul 22, 2026 · via day close
Latest settled
+4.69%
T+60 · $175.13
Vs SPY
+1.43%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 22 $167.28entry
  2. T+1 · 4mo ago +1.82%α +3.05% · $170.32
  3. T+5 · 4mo ago +6.52%α +8.92% · $178.18
  4. T+20 · 3mo ago +3.11%α +0.22% · $172.49
  5. T+60 · 5w ago +4.69%α +1.43% · $175.13
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

ICON plc filed a 6-K on July 22, 2026, solely to announce the scheduling of its Q2 2026 earnings release for July 29, 2026, and a conference call for July 30, 2026. This is a routine administrative filing with no financial results or material business updates. The filing's significance is elevated by the cross-filing context of the May 27, 2026 20-F, which disclosed a $92.7M revenue restatement for FY2024, material weaknesses in internal controls, and a $364.2M goodwill impairment, making this upcoming earnings call a high-stakes event for investors seeking clarity on the company's financial health and remediation progress.

Key Facts

  • ICON will release Q2 2026 financial results after market close on July 29, 2026.
  • A conference call to discuss results is scheduled for July 30, 2026 at 8:00 AM ET.
  • The filing is a routine earnings schedule announcement with no financial data or guidance.
  • Cross-filing context: the prior 20-F (May 27, 2026) disclosed a $92.7M FY2024 revenue overstatement, material weaknesses, and a $364.2M goodwill impairment, making this earnings release a key credibility test.

Financial Impact

No financial figures reported in this filing. The upcoming earnings release will be closely watched following the prior restatement of $92.7M in FY2024 revenue and a $364.2M goodwill impairment.

revenuenetIncomeguidance

Risk Factors

  • The prior restatement and material weaknesses create significant downside risk if Q2 results show further revenue recognition issues or guidance is withdrawn.
  • Nasdaq deficiency notice from delayed 20-F filing adds delisting overhang that could be triggered by further filing delays.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Commercial Physical & Biological Research
Analyst Consensus
67% bullish (24 analysts)

Investment Themes

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001628280-26-049100
Document: pressrelease-iconplcschedu.htm0001628280-26-049100
Document: 0001628280-26-049100-index-headers.html0001628280-26-049100
Document: 0001628280-26-049100-index.html0001628280-26-049100
Document: 0001628280-26-049100.txt0001628280-26-049100

Track record

25 reports on ICLR

Performance horizon

4 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +33.70% at T+60 after the Aug 6, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $190.43 Now $194.65 +2.22% settles Nov 17
  2. Nov 12, 20264d ago 144 Neutral 2/10 Entry $194.65 to $191.40 Now $194.65 −0.00% ▼ −1.67% +0.24% vs SPY
  3. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $204.63 to $199.70 Now $194.65 −4.88% ▼ −2.41% −3.73% vs SPY
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $201.65 to $204.74 Now $194.65 −3.47% ▲ +1.53% +1.22% vs SPY
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $203.11 to $201.65 Now $194.65 −4.17% ▼ −0.72% +3.69% vs SPY
  6. Nov 3, 202613d ago Insider Cluster Neutral 2/10 Entry $203.11 to $201.65 Now $194.65 −4.17% ▼ −0.72% +3.69% vs SPY
  7. Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $194.65 −4.48% ▼ −0.32% −1.98% vs SPY
  8. Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $194.65 −4.48% ▼ −0.32% −1.98% vs SPY
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $203.77 to $203.11 Now $194.65 −4.48% ▼ −0.32% −1.98% vs SPY
  10. Oct 27, 202620d ago 6-K Bearish 5/10 Entry $214.16 to $215.48 Now $194.65 +9.11% ▼ −0.62% −1.00% vs SPY
Showing 10 of 25

US Market Status

Market Closed · Opens Wed (12h 2m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 22, 2026